Cargando…
ODP084 Denosumab as a therapuetic modality in management of primary hyperparathyroidism induced severe hypercalcemia
BACKGROUND: Primary Hyperparathyroidism(due to parathyroid adenoma) is usually associated with smoldering clinical course due to effects of chronic hypercalcemia whereas malignancy related hypercalcemia is often associated with life threatening severe hypercalcemia. However in rare instances, hyperc...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625065/ http://dx.doi.org/10.1210/jendso/bvac150.328 |